Efficacy and Safety of Pitavastatin in Japanese Male Children with Familial Hypercholesterolemia-Reference-Cited by-同舟云学术

Efficacy and Safety of Pitavastatin in Japanese Male Children with Familial Hypercholesterolemia

Published:2016 Issue:1 Volume:23 Page:48-55
ISSN:1340-3478
Container-title:Journal of Atherosclerosis and Thrombosis
language:en
Short-container-title:JAT

Author:

Harada-Shiba Mariko¹,Arisaka Osamu²,Ohtake Akira³,Okada Tomoo⁴,Suganami Hideki⁵,

Affiliation:

1. Department of Molecular Innovation in Lipidology, National Cerebral and Cardiovascular Center Research Institute

2. Department of Pediatrics, Dokkyo Medical University School of Medicine

3. Department of Pediatrics, Faculty of Medicine, Saitama Medical University

4. Department of Pediatric and Child Health, Nihon University School of Medicine

5. Clinical Data Science Department, Kowa Company, Ltd.,

Publisher

Japan Atherosclerosis Society

Subject

Biochemistry (medical),Cardiology and Cardiovascular Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/jat/23/1/23_28753/_pdf

Reference14 articles.

1. 1)Harada-Shiba M, Arai H, Oikawa S, Ohta T, Okada T, Okamura T, Nohara A, Bujo H, Yokote K, Wakatsuki A, Ishibashi S, Yamashita S: Guidelines for the management of familial hypercholesterolemia. J Atheroscler Thromb, 2012; 19: 1043-1060

2. 2) Japan Atherosclerosis Society eds., Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2012, Japan Atherosclerosis Society; 2012

3. 3) Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents; National Heart, Lung, and Blood Institute: Expert Panel on Integrated Guidelines or Cardiovascular Health and Risk Reduction in Children and Adolescents: Summary Report. Pediatrics, 2011; 128 (Suppl5): S213-256

4. 4) Aoki T, Nishimura H, Nakagawa S, Kojima J, Suzuki H, Tamaki T, Wada Y, Yokoo N, Sato F, Kimata H, Kitahara M, Toyoda K, Sakashita M, Saito Y: Pharmacological profile of a novel synthetic inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A reductase. Arzneimittenforschung, 1997; 47: 904-909

5. 5) Morikawa S, Umetani M, Nakagawa S, Yamazaki H, Suganami H, Inoue K, Kitahara M, Hamakubo T, Kodama T, Saito Y: Relative induction of mRNA for HMG CoA reductase and LDL receptor by five different HMG-CoA reductase inhibitors in cultured human cells. J Atheroscler thromb, 2000; 7: 138-144

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Guidelines for the Diagnosis and Treatment of Adult Familial Hypercholesterolemia 2022;Journal of Atherosclerosis and Thrombosis;2023-05-01

2. Guidelines for the Diagnosis and Treatment of Pediatric Familial Hypercholesterolemia 2022;Journal of Atherosclerosis and Thrombosis;2023-05-01

3. Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2022;Journal of Atherosclerosis and Thrombosis;2023

4. Hyperlipidemia in Children and Adolescents;Cardiology in Review;2022-06-14

5. The Effect of Statins in Children and Adolescents With Familial Hypercholesterolemia: A Systematic Review;Journal of Pediatric Health Care;2021-05